SELLAS Life Sciences Group, Inc. (SLS) - Stock Prices, Stock Peers & Analysis

Home
SLS

Company Name	SELLAS Life Sciences Group, Inc.
Symbol	SLS
Currency	USD
Price	1.32
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	84,918,899
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	0.5 - 1.9
Industry	Biotechnology
Sector	Healthcare
CEO	Dr. Angelos M. Stergiou M.D., ScD h.c.
Website	https://www.sellaslifesciences.com

An error occurred while fetching data.

About SELLAS Life Sciences Group, Inc.

SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the